Downs Christopher S

SEC source: 0001705978-26-000004 · primary_doc.xml · nonDerivative · entry 2

Downs Christopher S · CIK 0001705978 · Interim CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Indirect · By Lincoln Hall Advisors LLC

Disclosed balance after: 2,248

F2 · price: Shares issued under the Issuer's 2024 Stock Incentive Plan pursuant to Section 2.b of the Consulting Agreement in satisfaction of the $5,000 monthly equity fee for September 2026, received in shares in lieu of cash. The number of shares equals $5,000 divided by the volume-weighted average price of the Issuer's common stock on the OTCQB Marketplace for all trading days in September 2026 ($5.6065), rounded down to the nearest whole share.

F3 · ownership.nature: The shares are held of record by Lincoln Hall Advisors LLC, a Wyoming limited liability company of which the Reporting Person is the sole member, through which the Reporting Person provides services to the Issuer.

SEC source: 0001705978-26-000004 · primary_doc.xml · nonDerivative · entry 1

Downs Christopher S · CIK 0001705978 · Interim CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Indirect · By Lincoln Hall Advisors LLC

Disclosed balance after: 1,357

F1 · price: Shares issued under the Issuer's 2024 Stock Incentive Plan pursuant to Section 2.b of the Consulting Agreement between the Issuer and Lincoln Hall Advisors LLC, effective August 1, 2026, in satisfaction of the $5,000 monthly equity fee for August 2026, received in shares in lieu of cash. The number of shares equals $5,000 divided by the volume-weighted average price of the Issuer's common stock on the OTCQB Marketplace for all trading days in August 2026 ($3.6820), rounded down to the nearest whole share.

F3 · ownership.nature: The shares are held of record by Lincoln Hall Advisors LLC, a Wyoming limited liability company of which the Reporting Person is the sole member, through which the Reporting Person provides services to the Issuer.

SEC source: 0001683168-25-008562 · ownership.xml · derivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,881

Underlying: Common Stock · 4,881 shares

Expires 2035-11-17

F1 · date: The option grant was approved by the compensation committee of CNS Pharmaceutical, Inc.'s board of directors on March 11, 2025 (the "Grant Date"), subject to shareholder approval of the stock option plan under which the option was granted. CNS Pharmaceutical, Inc.'s shareholders approved the plan at the company's annual meeting on November 17, 2025.

F3 · price: Issued in connection with the reporting person's employment with the Company.

F2 · derivative.exercise_date: The options set forth in the table vest as follows: 50% on the six-month anniversary of the Grant Date, 25% on the 12-month anniversary of the Grant Date, and 25% on the 18-month anniversary of the Grant Date, subject to the reporting person's continued employment on each vesting date.

SEC source: 0001683168-24-002286 · ownership.xml · derivative · entry 2

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 241.572

Underlying: Common Stock · 40,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Company common stock.

F2 · price: Issued in connection with the reporting person's employment with the Company.

F4 · derivative.exercise_date: The restricted stock units set forth in the table vest in eight equal quarterly installments over two years.

F4 · derivative.expiration_date: The restricted stock units set forth in the table vest in eight equal quarterly installments over two years.

SEC source: 0001683168-24-002286 · ownership.xml · derivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201.572

Underlying: Common Stock · 40,000 shares

Expires 2034-04-08

F2 · price: Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The options set forth in the table vest in 36 equal monthly installments over three years.

SEC source: 0001683168-24-000706 · ownership.xml · derivative · entry 3

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,572

Underlying: Common Stock · 66,666 shares

Expires 2025-10-01

F1 · price: The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.

SEC source: 0001683168-24-000706 · ownership.xml · derivative · entry 2

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,906

Underlying: Common Stock · 66,666 shares

Expires 2029-02-01

F1 · price: The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.

SEC source: 0001683168-24-000706 · ownership.xml · nonDerivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,438

F1 · price: The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.

SEC source: 0001683168-23-006001 · ownership.xml · nonDerivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,772

F1 · price: This transaction was executed in multiple trades at prices ranging from $1.2196 to $1.2999. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001683168-23-002829 · ownership.xml · derivative · entry 2

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,248

Underlying: Common Stock · 521 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · price: On April 28, 2022, the reporting person received 8,335 restricted stock units vesting as follows, subject to the grantee's continued service to the Company on each vesting date, (i) 25% of the grant will vest in four equal annual installments over 4 years; (ii) 25% of the grant will vest if within 24 months from issuance the average the closing price of the Issuer common stock over a ten trading day period exceeds $2.00 (subject to pro rata adjustment for stock splits or similar events); (iii) 25% of the grant will vest if within 36 months from issuance the average the closing price of the Issuer common stock over a ten trading day period exceeds $4.00 (subject to pro rata adjustment for stock splits or similar events); and (iv) 25% of the grant will vest if within 24 months from issuance the Issuer achieves positive interim, clinical data as determined by its Board of Directors.

F2 · derivative.exercise_date: On April 28, 2022, the reporting person received 8,335 restricted stock units vesting as follows, subject to the grantee's continued service to the Company on each vesting date, (i) 25% of the grant will vest in four equal annual installments over 4 years; (ii) 25% of the grant will vest if within 24 months from issuance the average the closing price of the Issuer common stock over a ten trading day period exceeds $2.00 (subject to pro rata adjustment for stock splits or similar events); (iii) 25% of the grant will vest if within 36 months from issuance the average the closing price of the Issuer common stock over a ten trading day period exceeds $4.00 (subject to pro rata adjustment for stock splits or similar events); and (iv) 25% of the grant will vest if within 24 months from issuance the Issuer achieves positive interim, clinical data as determined by its Board of Directors.

F2 · derivative.expiration_date: On April 28, 2022, the reporting person received 8,335 restricted stock units vesting as follows, subject to the grantee's continued service to the Company on each vesting date, (i) 25% of the grant will vest in four equal annual installments over 4 years; (ii) 25% of the grant will vest if within 24 months from issuance the average the closing price of the Issuer common stock over a ten trading day period exceeds $2.00 (subject to pro rata adjustment for stock splits or similar events); (iii) 25% of the grant will vest if within 36 months from issuance the average the closing price of the Issuer common stock over a ten trading day period exceeds $4.00 (subject to pro rata adjustment for stock splits or similar events); and (iv) 25% of the grant will vest if within 24 months from issuance the Issuer achieves positive interim, clinical data as determined by its Board of Directors.

SEC source: 0001683168-23-002829 · ownership.xml · nonDerivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,772

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001683168-23-002495 · ownership.xml · nonDerivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,251

SEC source: 0001683168-23-002095 · ownership.xml · derivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,768

Underlying: Common stock · 6,067 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one shares of Issuer common stock.

F3 · price: Issued in connection with the reporting person's employment with the Company.

F2 · derivative.exercise_date: The restricted stock units set forth in this table vest as follows, subject to the grantee's continued service to the Company on each vesting date, (i) 50% of the grant will vest in four equal annual installments over 4 years; (ii) 25% of the grant will vest if within 24 months from issuance the average the closing price of the Issuer common stock over a ten trading day period exceeds $6.00 (subject to pro rata adjustment for stock splits or similar events); and (iii) 25% of the grant will vest if within 36 months from issuance the average the closing price of the Issuer common stock over a ten trading day period exceeds $24.00 (subject to pro rata adjustment for stock splits or similar events).

F2 · derivative.expiration_date: The restricted stock units set forth in this table vest as follows, subject to the grantee's continued service to the Company on each vesting date, (i) 50% of the grant will vest in four equal annual installments over 4 years; (ii) 25% of the grant will vest if within 24 months from issuance the average the closing price of the Issuer common stock over a ten trading day period exceeds $6.00 (subject to pro rata adjustment for stock splits or similar events); and (iii) 25% of the grant will vest if within 36 months from issuance the average the closing price of the Issuer common stock over a ten trading day period exceeds $24.00 (subject to pro rata adjustment for stock splits or similar events).

SEC source: 0001683168-23-000760 · ownership.xml · derivative · entry 2

Downs Christopher · CIK 0001705978 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 6,300 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Issued upon conversion of restricted stock units, each of which represents a contingent right to receive one share of Issuer common stock.

F3 · price: Issued in connection with the reporting person's service as a director to the Issuer.

F2 · derivative.exercise_date: The restricted stock units set forth in this table were issued February 9, 2022 and vested on February 9, 2023, subject to the grantee's continued service to the Issuer on such vesting date.

F2 · derivative.expiration_date: The restricted stock units set forth in this table were issued February 9, 2022 and vested on February 9, 2023, subject to the grantee's continued service to the Issuer on such vesting date.

SEC source: 0001683168-23-000760 · ownership.xml · nonDerivative · entry 1

Downs Christopher · CIK 0001705978 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,300

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Issued upon conversion of restricted stock units, each of which represents a contingent right to receive one share of Issuer common stock.

SEC source: 0001683168-22-003054 · ownership.xml · derivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 681,000

Underlying: Common Stock · 250,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one shares of Issuer common stock.

F3 · price: Issued in connection with the reporting person's employment with the Company.

F2 · derivative.exercise_date: The restricted stock units set forth in this table vest as follows, subject to the grantee's continued service to the Company on each vesting date, (i) 25% of the grant will vest in four equal annual installments over 4 years; (ii) 25% of the grant will vest if within 24 months from issuance the average the closing price of the Issuer common stock over a ten trading day period exceeds $2.00 (subject to pro rata adjustment for stock splits or similar events); (iii) 25% of the grant will vest if within 36 months from issuance the average the closing price of the Issuer common stock over a ten trading day period exceeds $4.00 (subject to pro rata adjustment for stock splits or similar events); and (iv) 25% of the grant will vest if within 24 months from issuance the Issuer achieves positive interim, clinical data as determined by its Board of Directors.

F2 · derivative.expiration_date: The restricted stock units set forth in this table vest as follows, subject to the grantee's continued service to the Company on each vesting date, (i) 25% of the grant will vest in four equal annual installments over 4 years; (ii) 25% of the grant will vest if within 24 months from issuance the average the closing price of the Issuer common stock over a ten trading day period exceeds $2.00 (subject to pro rata adjustment for stock splits or similar events); (iii) 25% of the grant will vest if within 36 months from issuance the average the closing price of the Issuer common stock over a ten trading day period exceeds $4.00 (subject to pro rata adjustment for stock splits or similar events); and (iv) 25% of the grant will vest if within 24 months from issuance the Issuer achieves positive interim, clinical data as determined by its Board of Directors.

SEC source: 0001683168-22-001631 · ownership.xml · nonDerivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,500

SEC source: 0001683168-22-000872 · ownership.xml · derivative · entry 1

Downs Christopher · CIK 0001705978 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,300

Underlying: Common Stock · 6,300 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · price: Issued in connection with the reporting person's service as a director to the Issuer.

F2 · derivative.exercise_date: The restricted stock units set forth in this table vest on the earlier of one-year from the date of issuance or the date of the Issuer's next annual meeting of shareholders, subject to the grantee's continued service to the Issuer on such vesting date.

F2 · derivative.expiration_date: The restricted stock units set forth in this table vest on the earlier of one-year from the date of issuance or the date of the Issuer's next annual meeting of shareholders, subject to the grantee's continued service to the Issuer on such vesting date.

SEC source: 0001683168-21-006141 · ownership.xml · nonDerivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,500

F1 · price: This transaction was executed in multiple trades at prices ranging from $0.9400 to $0.947299. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001683168-21-005869 · ownership.xml · nonDerivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,500

F1 · price: This transaction was executed in multiple trades at prices ranging from $1.14 to $1.155. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001683168-21-000448 · ownership.xml · derivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 431,000

Underlying: Common Stock · 131,000 shares

Expires 2031-02-05

F2 · price: The stock options were issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest in four equal annual installments beginning on the first anniversary of the Transaction Date and are subject to the grantee's continued service to the Company on each vesting date.

SEC source: 0001683168-20-002862 · ownership.xml · nonDerivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,000

F1 · price: This transaction was executed in multiple trades at prices ranging from $1.84 to $2.30. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001683168-19-003571 · ownership.xml · derivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2029-11-13

F2 · price: The stock options were issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest in four equal annual installments beginning on the first anniversary of the Transaction Date and are subject to the grantee's continued service to the Company on each vesting date.

SEC source: 0001014108-17-000151 · primary_doc.xml · derivative · entry 1

Downs Christopher · CIK 0001705978 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2022-09-07

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests annually over three years beginning September 7, 2018.

SEC source: 0001014108-17-000135 · primary_doc.xml · nonDerivative · entry 1

Downs Christopher · CIK 0001705978 · CFO (interim)

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,840

SEC source: 0001014108-17-000099 · primary_doc.xml · derivative · entry 1

Downs Christopher · CIK 0001705978 · CFO (interim)

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2027-03-16

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 20,000 shares of InfuSystem Holdings, Inc. common stock, vests in 36-monthly installments beginning April 16, 2017.

SEC source: 0001014108-17-000098 · primary_doc.xml · derivative · entry 1

Downs Christopher · CIK 0001705978 · CFO (interim)

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2026-08-18

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 60,000 shares of InfuSystem Holdings, Inc. common stock, vests in 36-monthly installments beginning September 18, 2016.